Streetbeat News

Earnings

ABOS

Acumen Pharmaceuticals (NASDAQ:ABOS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.36. The company's past performance shows a trend of beating EPS estimates, which has often resulted in a positive impact on the share price. The stock is currently trading at $7.3 and has seen a 37.52% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:01 pm

MASS

908 Devices (NASDAQ:MASS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.33. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. The stock is currently trading at $6.23, down 66.56% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:01 pm

HBIO

Harvard Bioscience (NASDAQ:HBIO) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.05. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $4.83 and has seen a 34.52% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:01 pm

SWIM

Latham Group (NASDAQ:SWIM) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.12. The company's past performance shows a trend of missing EPS estimates, which has led to share price drops. The stock is currently trading at $3.84, down 33.74% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:01 pm

MVST

Microvast Holdings Inc (NASDAQ:MVST) reported better-than-expected Q2 financial results, with a revenue of $74.95 million, beating estimates of $64.19 million, and a loss of 2 cents per share, better than the estimated loss of 9 cents. The company's revenue increased by 16.4% YoY, and its backlog grew by 541.9% YoY to $675.9 million. The company expects Q3 revenue to be between $72 million and $80 million, and full-year revenue to be between $348 million and $368 million.

Portfolio Pulse from Adam Eckert

August 07, 2023 | 9:01 pm

BRBR

BellRing Brands (NYSE:BRBR) reported Q3 adjusted earnings of $0.34 per share, beating the analyst consensus estimate of $0.32 by 6.25%. This is a 9.68% increase over earnings of $0.31 per share from the same period last year. The company also reported quarterly sales of $445.90 million, beating the analyst consensus estimate of $441.43 million by 1.01%. This is a 20.32% increase over sales of $370.60 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 9:01 pm

MAC

Macerich (NYSE:MAC) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.42. The company's past performance shows a mix of EPS beats and misses, with corresponding price changes. Shares of Macerich were trading at $12.61 as of August 04, with a 52-week increase of 20.98%.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:01 pm

AOMR

Angel Oak Mortgage REIT (NYSE:AOMR) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.12. The company's past performance shows a pattern of share price changes following earnings reports. The shares were trading at $9.11 as of August 04, with a 52-week decrease of 37.16%.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:01 pm

CDNA

CareDx (NASDAQ:CDNA) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.31. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varying changes in the share price. The stock is currently trading at $11.1, down 54.0% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:01 pm

MX

MagnaChip Semiconductor (NYSE:MX) reported Q2 adjusted EPS of $(0.06), beating the estimate of $(0.23) by 73.91%. However, this is a 126.09% decrease from the same period last year. The company's quarterly sales of $60.98M also beat the estimate of $60.50M by 0.79%, but this is a 39.85% decrease from last year.

Portfolio Pulse from vinayak@benzinga.com

August 07, 2023 | 8:59 pm